ETMTC
ETMTC is an orally active anti-inflammatory and antioxidant agent. ETMTC inhibits IKK-mediated phosphorylation and degradation of IkBα, blocks nuclear translocation and activation of NF-κB, and reduces the expression of ICAM-1, VCAM-1, E-selectin, Th2 cytokines and eosinophil chemokines. ETMTC abrogates neutrophil adhesion to endothelial monolayers and inhibits TNF-α-induced ROS production. ETMTC activates Nrf2, and enhances the activities of mitochondrial complex I and IV. ETMTC reduces lipid peroxidation levels, oxidative DNA damage, cytochrome c and caspase 9 activity, and decreases goblet cell metaplasia and subepithelial fibrosis. ETMTC can be used for the research of inflammatory diseases and asthma.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 117666-86-1
- Fòrmula: C14H18O4S
- Peso molecular:282.36
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas Caspase
More
Actividad biológica
Descripciòn
|
NF-κB |
Caspase-9 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HUVEC | IC50 |
10 μg/mL
Compound: 54, ETMTC
|
Antiinflammatory activity against TNF-alpha-induced ICAM1 protein expression in HUVEC pretreated for 2 hrs before TNFalpha challenge measured after 16 hrs by whole cell ELISA
Antiinflammatory activity against TNF-alpha-induced ICAM1 protein expression in HUVEC pretreated for 2 hrs before TNFalpha challenge measured after 16 hrs by whole cell ELISA
|
[PMID: 21955679] |
In Vitro
ETMTC (2.5-20 μg/mL; 2 h pre-incubation) potently inhibits TNF-α-induced expression of ICAM-1, VCAM-1 and E-selectin in primary human umbilical vein endothelial cells, with an IC50 of 10 μg/mL for the inhibition of ICAM-1[1].
Pre-incubation with ETMTC (20 μg/mL) for 2 h inhibits the TNF-α-induced expression of ICAM-1, VCAM-1 and E-selectin on human primary umbilical vein endothelial cells by over 95%, as detected by flow cytometry[1].
ETMTC (2.5-20 μg/mL; 2 h pre-incubation) potently inhibits TNF-α-induced adhesion of neutrophils to primary human umbilical vein endothelial cells in a concentration-dependent manner[1].
ETMTC (compound 54) (70 μM; 1-6 h pre-treatment, 1-2 h post-treatment, 16 h total incubation) potently inhibits TNF-α-induced ICAM-1 expression in primary human umbilical vein endothelial cells. However, it exerts this effect only when administered before or concurrently with TNF-α treatment, and shows no such effect when administered after TNF-α induction[2].
ETMTC (70 μM; 2 h pre-treatment, 4 h TNF-α induction) significantly inhibits TNF-α-induced transcription of ICAM-1, VCAM-1 and E-selectin genes in primary human umbilical vein endothelial cells; it suppresses TNF-α-induced nuclear translocation of the NF-κB p65 subunit in primary human umbilical vein endothelial cells; and it inhibits TNF-α-induced activation of NF-κB in primary human umbilical vein endothelial cells and A549 lung epithelial cells[2].
ETMTC (70 μM; 2-4 h pre-treatment, 5-60 min TNF-α induction) inhibits TNF-α-induced phosphorylation and degradation of IkBα, as well as suppresses IKK kinase activity, in human primary umbilical vein endothelial cells[2].
ETMTC (70 μM; 2 h pre-treatment, 30 min TNF-α induction) completely inhibits TNF-α-induced reactive oxygen species production in primary human umbilical vein endothelial cells[2].
ETMTC (0.01-20 μM; 16 h) induces concentration-dependent expression of Nrf2-regulated antioxidant genes GCLM, HO1, and NQO1 in human bronchial epithelial cells Beas-2B[2].
ETMTC (5-10 μM; 16 h) upregulates the expression levels of Nrf2-regulated antioxidant proteins NQO1 and HO1, downregulates the level of Nrf2 inhibitor Keap1, and upregulates the level of Nrf2 activator DJ-1 in human bronchial epithelial cells Beas-2B[2].
ETMTC (0.01-10 μM; 16 h) induces concentration-dependent activation of Nrf2-mediated transcription in human bronchial epithelial cells Beas-2B[2].
ETMTC (10 μM; 24 h) activates the expression of Nrf2-regulated antioxidant genes in Beas-2B human bronchial epithelial cells in a reactive oxygen species-dependent manner[2].
ETMTC (0.01-20 μM) inhibits TNF-α-induced reactive oxygen species production in human endothelial cells and induces concentration-dependent expression of Nrf2-regulated antioxidant genes in human bronchial epithelial cells[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:primary human umbilical cord endothelial cells
-
Concentration:70 μM
-
Incubation Time:1, 2, 4, 6 h (pre-treatment); 1, 2 h (post-treatment); 16 h (total incubation)
-
Result:Significantly inhibited TNF-α-induced ICAM-1 expression when added prior to or simultaneously with TNF-α, with pre-treatment showing time-dependent efficacy.
Did not significantly inhibit TNF-α-induced ICAM-1 expression when added after TNF-α induction.
-
Cell Line:primary human umbilical cord endothelial cells
-
Concentration:70 μM
-
Incubation Time:2 h pre-treatment; 4 h TNF-α induction
-
Result:Significantly reduced TNF-α-induced transcript levels of ICAM-1, VCAM-1, and E-selectin.
Had no effect on basal transcript levels of ICAM-1, VCAM-1, and E-selectin.
Did not alter β-actin transcript levels.
-
Cell Line:primary human umbilical cord endothelial cells
-
Concentration:70 μM
-
Incubation Time:2 h pre-treatment; 30 min TNF-α induction
-
Result:Prevented TNF-α-induced decrease in cytoplasmic NF-κB p65 levels.
Prevented TNF-α-induced increase in nuclear NF-κB p65 levels.
Had no effect on basal NF-κB p65 localization.
-
Cell Line:Beas-2B human bronchial epithelial cells
-
Concentration:0.01, 0.1, 1, 5, 10, 20 μM
-
Incubation Time:16 h
-
Result:Caused concentration-dependent increase in GCLM, HO1, and NQO1 transcript levels.
Induced initial increases in GCLM, HO1, and NQO1 transcript levels at 1 μM, with robust induction at 20 μM.
Induced significantly higher levels of GCLM, HO1, and NQO1 genes at 10 μM compared to sulforaphane at the same concentration.
-
Cell Line:Beas-2B human bronchial epithelial cells
-
Concentration:5, 10 μM
-
Incubation Time:16 h
-
Result:Significantly increased protein levels of NQO1 and HO1 in a concentration-dependent manner.
Significantly decreased protein levels of the Nrf2 inhibitor Keap1.
Significantly increased protein levels of the Nrf2 activator DJ-1.
-
Cell Line:Beas-2B human bronchial epithelial cells
-
Concentration:10 μM (alone or with 10 mM NAC)
-
Incubation Time:24 h
-
Result:Significantly increased GCLM, HO1, and NQO1 transcript levels when applied alone.
Had its induced increase in GCLM, HO1, and NQO1 transcript levels completely abolished by co-treatment with NAC.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (8-10 week old male; ovalbumin-sensitized and challenged asthma model)[4]
-
Dosage:0.1 mg/kg; 1 mg/kg; 10 mg/kg; 15 mg/kg
-
Administration:p.o.; twice daily; 12 days
-
Result:Boosted MCh PC200 Penh vs OVA vehicle; 10 mg/kg served as optimal dose.
Cut airway resistance, inflammation scores, lung ICAM-1/VCAM-1/E-selectin/IL-4/IL-5/eotaxin/8-isoprostane.
Suppressed lung NF-κB, serum OVA-IgE/IgG1; restored mitochondrial I/IV; lowered cytochrome c/caspase 9.
Lessened BALF 8-OHdG, epithelial TUNEL, goblet metaplasia/collagen buildup; recovered 15-(S)-HETE.
Chemical Information
-
No. CAS 117666-86-1
-
Peso molecular 282.36
-
Fòrmula C14H18O4S
-
SMILES
S=C(/C=C/C1=CC(OC)=C(C(OC)=C1)OC)OCC
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
Naïve CD4+ T-cell subset differentiation/polarization
Naïve CD4+ T-cell subset differentiation/polarization is an in vitro assay in which purified naïve CD4+ T cells are activated through TCR and CD28 costimulation and cultured with defined cytokines and neutralizing antibodies to generate Th0, Th1, Th2, Th17, or induced Treg-like populations. Differentiation is detected by subset-associated cytokines and transcription factors: IFN-γ/T-bet for Th1, IL-4/GATA3 for Th2, IL-17A/RORγt for Th17, and Foxp3 for induced Treg cells. The assay readout is usually generated by intracellular cytokine staining after restimulation, transcription-factor staining by flow cytometry, ELISA of secreted cytokines, or gene-expression analysis. The result reflects cytokine-directed lineage commitment or polarization rather than antigen-specific immune protection by itself.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Connective Tissue: Masson's Trichrome/Collagen Trichrome Staining
Masson’s Trichrome (collagen/trichrome staining) is a histological technique that differentially stains tissue compartments using sequential acidic dyes to distinguish collagen from muscle and cytoplasmic components based on dye affinity and tissue permeability differences, enabling visualization of fibrosis and connective tissue architecture in histological sections. The classical formulation typically uses Weigert's iron hematoxylin for nuclear staining, Biebrich scarlet-acid fuchsin for cytoplasm and muscle, and aniline blue (or light green variants) for collagen, producing a characteristic blue/green collagen signal contrasted against red cytoplasm and dark nuclei. The staining principle relies on selective displacement of smaller dye molecules by larger anionic dyes in collagen-rich regions under controlled acidified conditions, which enhances collagen-specific dye retention. This property makes the method widely used for fibrosis assessment in organs such as heart, liver, lung, a
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Cytoplasmic-Nuclear Fractionated Protein Extraction
Cytoplasmic-nuclear fractionated protein extraction separates soluble cytoplasmic proteins from nuclear-enriched proteins by mild plasma-membrane permeabilization, differential centrifugation, washing of nuclei, and extraction of nuclear proteins for downstream immunoblotting or related molecular analysis. The readout is the relative abundance of a protein in cytoplasmic and nuclear fractions, commonly assessed by western blotting together with compartment markers such as tubulin or pyruvate kinase for cytoplasm and lamin, nucleoporin, hnRNP, H2AX, or Lamin B for nuclear fractions.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Pureza y Documentación
Referencias
[1]. Kumar S, et al. Novel natural product-based cinnamates and their thio and thiono analogs as potent inhibitors of cell adhesion molecules on human endothelial cells. European journal of medicinal chemistry. 2011 Nov;46(11):5498-511. [Content Brief]
[2]. Kumar S, et al. Ethyl 3',4',5'-trimethoxythionocinnamate modulates NF-κB and Nrf2 transcription factors. European journal of pharmacology. 2013 Jan 30;700(1-3):32-41. [Content Brief]
[3]. Kumar S, et al. Anti-inflammatory and antioxidant properties of Piper species: a perspective from screening to molecular mechanisms. Current topics in medicinal chemistry. 2015;15(9):886-93. [Content Brief]
[4]. Kumar S, et al. A novel cinnamate derivative attenuates asthma features and reduces bronchial epithelial injury in mouse model. International immunopharmacology. 2013 Jan;15(1):150-9. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)